Dr. Venk Betapudi

About

From discovery to application and impact.

“My career has been defined by a recurring journey: identify an important scientific problem, develop the tools and evidence needed to understand it, and translate that knowledge into something useful.”

More than two decades of scientific experience across discovery research, biotechnology, therapeutic development, medical countermeasures and federal research programs.

  1. Discovery
  2. Development
  3. Translation
  4. Leadership
  5. Impact
Dr. Venk Betapudi pipetting samples at a laboratory bench

Career story

A path that keeps moving from bench to impact

  1. Discovery

    Early biotechnology and biochemical research

    Designed a bioreactor for continuous production of glucose-1-phosphate from starch using eggshell-powder-bound starch phosphorylases (Journal of Biotechnology, 1994).

  2. Technology

    Biotechnology innovation

    Developed an efficient recombinant baculovirus expression system for high-level protein expression in insect cells — U.S. Patent 5,965,393.

  3. Discovery

    Molecular and cellular biology

    Discovered the novel protein kinases VwkA and MhckD (Molecular Biology of the Cell, 2005 and 2006) and developed a method to delete two genes in a single transfection (BioTechniques, 2004).

  4. Discovery

    Cancer and vascular biology

    Revealed contrasting roles of non-muscle myosin IIA and IIB in cancer cell migration and metastasis (Cancer Research, 2006), identified mechanisms of pathological microvesicle release in antiphospholipid syndrome (Blood, 2012 and 2013), and showed a kininogen fragment suppresses angiogenesis and tumor growth (FASEB Journal and Blood, 2016).

  5. Translation

    Therapeutic and nanoparticle development

    Tested synthetic nanoparticles for controlling an autoimmune bleeding disorder at the Cleveland Clinic, including pharmacokinetics, pharmacodynamics, anti-drug antibodies and biodistribution (Journal of Thrombosis and Haemostasis).

  6. Translation

    Gene therapy and viral vectors

    Engineered an adeno-associated viral vector-based therapy that provides complete protection against neurotoxic nerve agents at USAMRICD (Science Translational Medicine, 2020).

  7. Leadership

    Medical countermeasures and federal WMD programs

    Proposed research areas — live detectors, trigger technologies and chem-biosurveillance — for DHS Research and Development, and performed chemical and biological WMD data analysis with briefings to CWMD leadership.

  8. Leadership

    Research program leadership

    Conducted scientific review, coordinated stakeholders and prepared a 246-page annual report on blast overpressure and brain injury for the Defense Secretary.

  9. Impact

    Scientific communication

    Senior author of a widely cited gene therapy review (Frontiers in Oncology, 2019), Associate Editor at Frontiers, and plasmid vectors shared with more than 250 laboratories through Addgene.

  10. Impact

    AI, innovation, and creative work

    Today, exploring how AI can help move from information to insight, from insight to communication, and from communication to action.

Training

Education

PhD
Biotechnology
Devi Ahilya University, Indore, India
MS
Biochemistry
Devi Ahilya University, Indore, India
BS
Chemistry
Acharya Nagarjuna University, Guntur, India
Work With Me →